Kopp Family Office, LLC Activity Q4 2019-Q3 2023

Add to watchlist
Q3 2023
 Value Shares↓ Weighting
VEA SellVANGUARD TAX-MANAGED FDSvan ftse dev mkt$28,048
-5.4%
641,545
-0.0%
17.75%
+11.5%
IWM SellISHARES TRrussell 2000 etf$27,610
-21.0%
123,175
-14.4%
17.48%
-6.9%
VWO SellVANGUARD INTL EQUITY INDEX Fftse emr mkt etf$16,361
-3.7%
417,265
-0.1%
10.36%
+13.5%
VCEL SellVericel Corporation$15,400
-13.8%
459,415
-3.4%
9.75%
+1.6%
NEO BuyNeoGenomics Inc$12,874
-20.3%
1,046,639
+4.1%
8.15%
-6.1%
ExitCoherent Corp$0–-50,338–-1.38%–
Q2 2023
 Value Shares↓ Weighting
IWM NewISHARES TRrussell 2000 etf$34,937–143,975–18.76%–
VEA NewVANGUARD TAX-MANAGED FDSvan ftse dev mkt$29,640–641,845–15.92%–
FIVN NewFive9 Inc$20,590–249,722–11.06%–
VCEL NewVericel Corporation$17,861–475,415–9.59%–
VWO NewVANGUARD INTL EQUITY INDEX Fftse emr mkt etf$16,985–417,515–9.12%–
NEO NewNeoGenomics Inc$16,153–1,005,139–8.68%–
JAMF NewJAMF HOLDING CORP$9,312–477,026–5.00%–
TEAM NewAtlassian Corp PLCcl a$8,335–49,670–4.48%–
MODN NewModel N Inc$7,932–224,335–4.26%–
WK NewWorkiva Inc$7,765–76,386–4.17%–
INSP NewInspire Med Sys Inc$5,880–18,112–3.16%–
VRDN NewViridian Therapeutics Inc$5,098–214,290–2.74%–
MITK NewMITEK SYS INC$2,688–248,005–1.44%–
NewCoherent Corp$2,566–50,338–1.38%–
IVV NewISHARES TRcore s&p500 etf$99–223–0.05%–
ISTB NewISHARES TRcore 1 5 yr usd$97–2,070–0.05%–
IEFA NewISHARES TRcore msci eafe$95–1,400–0.05%–
IEMG NewISHARES TRcore msci emkt$57–1,150–0.03%–
IAGG NewISHARES TRcore intl aggr$40–806–0.02%–
IMTB NewISHARES TRcr 5 10 yr etf$36–834–0.02%–
IJH NewISHARES TRcore s&p mcp etf$30–113–0.02%–
IJR NewISHARES TRcore s&p scp etf$16–164–0.01%–
Q4 2022
 Value Shares↓ Weighting
IJR ExitISHARES TRcore s&p scp etf$0–-169–-0.01%–
IJH ExitISHARES TRcore s&p mcp etf$0–-122–-0.02%–
IMTB ExitISHARES TRcr 5 10 yr etf$0–-834–-0.03%–
IAGG ExitISHARES TRcore intl aggr$0–-862–-0.03%–
IVV ExitISHARES TRcore s&p500 etf$0–-234–-0.07%–
ISTB ExitISHARES TRcore 1 5 yr usd$0–-2,228–-0.08%–
MITK ExitMITEK SYS INC$0–-254,255–-1.90%–
VCEL ExitVericel Corporation$0–-552,963–-10.44%–
IEMG ExitISHARES TRcore msci emkt$0–-304,145–-10.64%–
FIVN ExitFive9, Inc.$0–-175,178–-10.69%–
NEO ExitNeoGenomics Inc.$0–-1,539,113–-10.79%–
JAMF ExitJAMF HOLDING CORP$0–-623,443–-11.24%–
IEFA ExitISHARES TRcore msci eafe$0–-389,922–-16.72%–
HZNP ExitHorizon Therapeutics Public Limited Company$0–-542,543–-27.33%–
Q3 2022
 Value Shares↓ Weighting
HZNP SellHorizon Therapeutics Public Limited Company$33,578,000
-22.6%
542,543
-0.3%
27.33%
-10.3%
IEFA SellISHARES TRcore msci eafe$20,537,000
-10.7%
389,922
-0.2%
16.72%
+3.5%
JAMF BuyJAMF HOLDING CORP$13,815,000
-10.2%
623,443
+0.4%
11.24%
+4.0%
NEO SellNeoGenomics Inc.$13,252,000
+0.7%
1,539,113
-4.7%
10.79%
+16.6%
FIVN BuyFive9, Inc.$13,135,000
-17.4%
175,178
+0.4%
10.69%
-4.3%
IEMG SellISHARES TRcore msci emkt$13,072,000
-12.6%
304,145
-0.2%
10.64%
+1.3%
VCEL SellVericel Corporation$12,829,000
-7.9%
552,963
-0.0%
10.44%
+6.8%
MITK BuyMITEK SYS INC$2,329,000
+0.4%
254,255
+1.3%
1.90%
+16.3%
Q2 2022
 Value Shares↓ Weighting
HZNP NewHorizon Therapeutics Public Limited Company$43,393,000–544,043–30.48%–
IEFA NewISHARES TRcore msci eafe$22,994,000–390,722–16.15%–
FIVN NewFive9, Inc.$15,902,000–174,478–11.17%–
JAMF NewJAMF HOLDING CORP$15,388,000–621,243–10.81%–
IEMG NewISHARES TRcore msci emkt$14,951,000–304,745–10.50%–
VCEL NewVericel Corporation$13,924,000–552,973–9.78%–
NEO NewNeoGenomics Inc.$13,166,000–1,615,513–9.25%–
MITK NewMITEK SYS INC$2,320,000–251,055–1.63%–
ISTB NewISHARES TRcore 1 5 yr usd$106,000–2,228–0.07%–
IVV NewISHARES TRcore s&p500 etf$89,000–234–0.06%–
IAGG NewISHARES TRcore intl aggr$43,000–862–0.03%–
IMTB NewISHARES TRcr 5 10 yr etf$37,000–834–0.03%–
IJH NewISHARES TRcore s&p mcp etf$28,000–122–0.02%–
IJR NewISHARES TRcore s&p scp etf$16,000–169–0.01%–
Q4 2021
 Value Shares↓ Weighting
IJR ExitISHARES TRcore s&p scp etf$0–-207–-0.01%–
IMTB ExitISHARES TRcr 5 10 yr etf$0–-764–-0.02%–
IJH ExitISHARES TRcore s&p mcp etf$0–-147–-0.02%–
IAGG ExitISHARES TRcore intl aggr$0–-783–-0.02%–
ISTB ExitISHARES TRcore 1 5 yr usd$0–-2,050–-0.04%–
IVV ExitISHARES TRcore s&p500 etf$0–-292–-0.05%–
MITK ExitMITEK SYS INC$0–-95,898–-0.70%–
FIVN ExitFive9, Inc.$0–-91,547–-5.80%–
IEMG ExitISHARES TRcore msci emkt$0–-267,266–-6.55%–
JAMF ExitJAMF HOLDING CORP$0–-552,910–-8.45%–
IEFA ExitISHARES TRcore msci eafe$0–-338,628–-9.98%–
VCEL ExitVericel Corporation$0–-549,775–-10.65%–
HZNP ExitHorizon Therapeutics Public Limited Company$0–-540,895–-23.52%–
NEO ExitNeoGenomics Inc.$0–-1,785,605–-34.19%–
Q3 2021
 Value Shares↓ Weighting
NEO SellNeoGenomics Inc.$86,138,000
-5.8%
1,785,605
-11.8%
34.19%
-9.6%
HZNP SellHorizon Therapeutics Public Limited Company$59,250,000
+15.7%
540,895
-1.1%
23.52%
+11.0%
VCEL BuyVericel Corporation$26,829,000
-5.3%
549,775
+1.9%
10.65%
-9.2%
IEFA SellISHARES TRcore msci eafe$25,143,000
-1.3%
338,628
-0.4%
9.98%
-5.3%
JAMF BuyJAMF HOLDING CORP$21,299,000
+116.2%
552,910
+88.4%
8.45%
+107.4%
IEMG SellISHARES TRcore msci emkt$16,506,000
-9.3%
267,266
-1.7%
6.55%
-13.1%
FIVN BuyFive9, Inc.$14,624,000
-12.9%
91,547
+0.0%
5.80%
-16.5%
MITK NewMITEK SYS INC$1,774,000–95,898–0.70%–
Q2 2021
 Value Shares↓ Weighting
NEO NewNeoGenomics Inc.$91,395,000–2,023,355–37.83%–
HZNP NewHorizon Therapeutics Public Limited Company$51,200,000–546,775–21.19%–
VCEL NewVericel Corporation$28,322,000–539,475–11.72%–
IEFA NewISHARES TRcore msci eafe$25,462,000–340,128–10.54%–
IEMG NewISHARES TRcore msci emkt$18,206,000–271,766–7.54%–
FIVN NewFive9, Inc.$16,785,000–91,527–6.95%–
JAMF NewJAMF HOLDING CORP$9,851,000–293,460–4.08%–
IVV NewISHARES TRcore s&p500 etf$126,000–292–0.05%–
ISTB NewISHARES TRcore 1 5 yr usd$105,000–2,050–0.04%–
IAGG NewISHARES TRcore intl aggr$43,000–783–0.02%–
IJH NewISHARES TRcore s&p mcp etf$40,000–147–0.02%–
IMTB NewISHARES TRcr 5 10 yr etf$39,000–764–0.02%–
IJR NewISHARES TRcore s&p scp etf$23,000–207–0.01%–
Q4 2020
 Value Shares↓ Weighting
IJR ExitISHARES TRcore s&p scp etf$0–-207–-0.01%–
IEMG ExitISHARES TRcore msci emkt$0–-316–-0.01%–
IJH ExitISHARES TRcore s&p mcp etf$0–-147–-0.02%–
IMTB ExitISHARES TRcr 5 10 yr etf$0–-764–-0.02%–
IAGG ExitISHARES TRcore intl aggr$0–-783–-0.02%–
IEFA ExitISHARES TRcore msci eafe$0–-1,178–-0.04%–
IVV ExitISHARES TRcore s&p500 etf$0–-292–-0.05%–
ISTB ExitISHARES TRcore 1 5 yr usd$0–-2,050–-0.06%–
XENT ExitIntersect ENT Inc.$0–-77,630–-0.69%–
FIVN ExitFive9, Inc.$0–-66,525–-4.69%–
VCEL ExitVericel Corporation$0–-1,150,735–-11.58%–
HZNP ExitHorizon Therapeutics Public Limited Company$0–-427,465–-18.04%–
NEO ExitNeoGenomics Inc.$0–-3,233,015–-64.78%–
Q3 2020
 Value Shares↓ Weighting
NEO SellNeoGenomics Inc.$119,266,000
-17.4%
3,233,015
-30.6%
64.78%
-17.0%
HZNP BuyHorizon Therapeutics Public Limited Company$33,205,000
+88.9%
427,465
+35.1%
18.04%
+89.9%
VCEL BuyVericel Corporation$21,323,000
+42.6%
1,150,735
+6.3%
11.58%
+43.3%
FIVN BuyFive9, Inc.$8,627,000
+21.8%
66,525
+4.0%
4.69%
+22.5%
ISTB NewISHARES TRcore 1 5 yr usd$106,000–2,050–0.06%–
IVV NewISHARES TRcore s&p500 etf$98,000–292–0.05%–
IEFA NewISHARES TRcore msci eafe$71,000–1,178–0.04%–
IAGG NewISHARES TRcore intl aggr$44,000–783–0.02%–
IMTB NewISHARES TRcr 5 10 yr etf$40,000–764–0.02%–
IJH NewISHARES TRcore s&p mcp etf$27,000–147–0.02%–
IEMG NewISHARES TRcore msci emkt$17,000–316–0.01%–
IJR NewISHARES TRcore s&p scp etf$15,000–207–0.01%–
Q2 2020
 Value Shares↓ Weighting
NEO NewNeoGenomics Inc.$144,424,000–4,661,835–78.03%–
HZNP NewHorizon Therapeutics Public Limited Company$17,581,000–316,325–9.50%–
VCEL NewVericel Corporation$14,955,000–1,082,155–8.08%–
FIVN NewFive9, Inc.$7,082,000–63,995–3.83%–
XENT NewIntersect ENT Inc.$1,051,000–77,630–0.57%–

Compare quarters

Export Kopp Family Office, LLC's holdings

CSVXLS